Shangxin Lu

404 total citations
11 papers, 307 citations indexed

About

Shangxin Lu is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Geriatrics and Gerontology. According to data from OpenAlex, Shangxin Lu has authored 11 papers receiving a total of 307 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cardiology and Cardiovascular Medicine, 2 papers in Internal Medicine and 2 papers in Geriatrics and Gerontology. Recurrent topics in Shangxin Lu's work include Atrial Fibrillation Management and Outcomes (6 papers), Cardiac Arrhythmias and Treatments (4 papers) and Cardiac electrophysiology and arrhythmias (3 papers). Shangxin Lu is often cited by papers focused on Atrial Fibrillation Management and Outcomes (6 papers), Cardiac Arrhythmias and Treatments (4 papers) and Cardiac electrophysiology and arrhythmias (3 papers). Shangxin Lu collaborates with scholars based in China, Australia and Canada. Shangxin Lu's co-authors include Ki H. Chon, Ernst A. Raeder, Changsheng Ma, Jianzeng Dong, Rong Bai, Ribo Tang, Xin Du, Shijun Xia, Sanshuai Chang and Caihua Sang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Biomedical Engineering.

In The Last Decade

Shangxin Lu

10 papers receiving 297 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shangxin Lu China	6	291	75	55	17	12	11	307
Frida Sandberg Sweden	12	381 1.3×	62 0.8×	121 2.2×	70 4.1×	12 1.0×	54	444
J. de Bie Italy	9	221 0.8×	37 0.5×	100 1.8×	18 1.1×	33 2.8×	27	277
Remo Leber Switzerland	8	242 0.8×	57 0.8×	55 1.0×	30 1.8×	24 2.0×	18	271
Michael Ringborn Sweden	11	449 1.5×	39 0.5×	74 1.3×	19 1.1×	39 3.3×	27	466
Simona Petrutiu United States	8	336 1.2×	92 1.2×	38 0.7×	7 0.4×	3 0.3×	10	366
Naren Wulan United Kingdom	4	304 1.0×	171 2.3×	59 1.1×	6 0.4×	48 4.0×	5	338
Rutger R van de Leur Netherlands	10	214 0.7×	42 0.6×	24 0.4×	16 0.9×	25 2.1×	24	269
Dirk Q. Feild United States	10	282 1.0×	72 1.0×	65 1.2×	55 3.2×	9 0.8×	18	292
Iain Sim United Kingdom	12	352 1.2×	12 0.2×	22 0.4×	14 0.8×	18 1.5×	33	415
Chih‐Min Liu Taiwan	11	280 1.0×	22 0.3×	28 0.5×	25 1.5×	23 1.9×	60	333

Countries citing papers authored by Shangxin Lu

Since Specialization

Citations

This map shows the geographic impact of Shangxin Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shangxin Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shangxin Lu more than expected).

Fields of papers citing papers by Shangxin Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shangxin Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shangxin Lu. The network helps show where Shangxin Lu may publish in the future.

Co-authorship network of co-authors of Shangxin Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Shangxin Lu. A scholar is included among the top collaborators of Shangxin Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shangxin Lu. Shangxin Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Wang, Shan, Wen Tang, Shangxin Lu, et al.. (2025). Development and Validation of a Diagnostic Nomogram Model for Predicting Cognitive Frailty in Acute Coronary Syndrome. Clinical Interventions in Aging. Volume 20. 1015–1027.

Du, Xin, Shangxin Lu, Chao Jiang, et al.. (2021). Incidence and predictors of hospitalization in patients with atrial fibrillation: results from the Chinese atrial fibrillation registry study. BMC Cardiovascular Disorders. 21(1). 146–146. 8 indexed citations

Sang, Caihua, Xin Du, Liu He, et al.. (2020). Effectiveness and safety of atrial fibrillation ablation in females. Pacing and Clinical Electrophysiology. 43(6). 583–592. 11 indexed citations

Jia, Zhixin, Shijun Xia, Liu He, et al.. (2020). [The thromboembolism risk of low-risk atrial fibrillation patients with different clinical characteristics].. PubMed. 48(9). 735–739. 1 indexed citations

Lu, Shangxin, Xin Du, Xiaoyi Yang, et al.. (2020). Physical activity and atrial tachyarrhythmia recurrence in atrial fibrillation patients after catheter ablation. Pacing and Clinical Electrophysiology. 43(9). 922–929. 4 indexed citations

Su, Xin, Xin Du, Shangxin Lu, et al.. (2020). Catheter ablation for atrial fibrillation is associated with reduced risk of mortality in the elderly: a prospective cohort study and propensity score analysis.. PubMed. 17(12). 740–749. 7 indexed citations

Du, Xin, Shangxin Lu, Xiaoyi Yang, et al.. (2019). Effect of Mental Health Status on Arrhythmia Recurrence After Catheter Ablation of Atrial Fibrillation. Canadian Journal of Cardiology. 35(7). 831–839. 10 indexed citations

Du, Xin, Mengmeng Li, Shangxin Lu, et al.. (2019). Frailty and Anticoagulant Therapy in Patients Aged 65 Years or Older with Atrial Fibrillation. SHILAP Revista de lepidopterología. 4(3). 4 indexed citations

Lu, Shangxin, et al.. (2018). Risk Factors for Cardiac Rupture Complicating Myocardial Infarction: A PRISMA Meta-Analysis and Systematic Review. Journal of Investigative Medicine. 67(4). 720–728. 7 indexed citations

10.

Chon, Ki H., et al.. (2009). Automatic Real Time Detection of Atrial Fibrillation. Annals of Biomedical Engineering. 37(9). 1701–1709. 251 indexed citations

11.

Liu, Hongyun, et al.. (2009). Phase II study of sorafenib combined with gemcitabine and 5-fluorouracil in patients with metastatic renal cell carcinoma: Preliminary results. Journal of Clinical Oncology. 27(15_suppl). e16093–e16093. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact